Abstract
| INTRODUCTION
IBD is a chronic inflammatory disorder that primarily involves the gastrointestinal tract. IBD has been described in a variety of immunedysregulated states, including common variable immunodeficiency disease, as well as chronic granulomatous disease, which has gastrointestinal findings that closely resemble CD. [1] [2] [3] As with other patients, the trigger for IBD onset in transplant recipients remains unclear, although some posit that transplant recipients' immunosuppressive medications may play a role in intestinal inflammation. In adult studies, the annual incidence of de novo IBD following solid organ transplant has been estimated at 20 cases per 100 000. 4 IBD has also been described in a few patients who are immunosuppressed following pediatric solid organ transplant. [5] [6] [7] We describe nine pediatric patients with de novo IBD following liver or kidney transplant. We hypothesize that de novo IBD following solid organ transplant has histologic findings and treatment responses that make it distinct from classic categories of IBD such as ulcerative colitis (UC) or CD. Future research and management of this pathologic process could be aided by identifying unique disease characteristics of de novo IBD after solid organ transplant and allow for larger studies that examine the role of immunosuppressive medications.
identified. Three patients, all liver recipients, had a pretransplant diagnosis of ulcerative colitis or primary sclerosing cholangitis. Two hundred and ninety-nine transplant recipients (126 liver, 170 kidney, and three combined) continue to be followed at UCSF either in the pediat- 
| RESULTS
Nine children (six liver transplant, two kidney transplants, one com- 
| DISCUSSION
This is a retrospective case series of nine children who developed de novo, chronic post-transplant IBD-like illness following a solid organ transplant, representing almost 4% of all liver and kidney recipients transplanted at our pediatric institution. In comparison, recent studies have estimated the prevalence of CD and UC in children younger than 20 years is 43 per 100 000 (95% CI, 40-45) and 28 (95% CI, 26-30), respectively. 10 Our study suggests that the prevalence of IBD-like enteritis is higher in the solid organ transplant recipient; however, this would need to be further explored and confirmed with multicenter data.
The majority of the patients in this series presented with prolonged, non-infectious diarrhea and hematochezia and additionally had histologic findings classically associated with IBD such as granulomas (Table 2) . While non-infectious diarrhea is often attributed to immunosuppressive medications such as mycophenolate mofetil, in this case series at least five children developed symptoms with no current exposure to this medication. This suggests that immunosuppressive medications are not solely responsible for the development of IBD symptoms.
Recent studies have associated tacrolimus immunosuppression with the development of de novo food allergy and eosinophilic gastritis. This study is a single-center, retrospective chart review. Sample size is small, but IBD diagnosis was histologically confirmed clinically at diagnosis and again at data analysis to ensure that we captured cases accurately. Cases were identified by retrospective chart review at our pediatric institution; thus, we were unable to identify whether any patients who had underwent transplant at our institution but had transitioned to adult care or another transplant center had gone on to develop IBD-like enteritis. While this hinders the ability to provide an accurate incidence of this phenomenon, we are still able 
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